{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T06:55:35Z","timestamp":1772175335570,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.radonc.2020.06.048","type":"journal-article","created":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T21:19:00Z","timestamp":1593724740000},"page":"10-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["4D CT analysis of organs at risk (OARs) in stereotactic radiotherapy"],"prefix":"10.1016","volume":"151","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7347-0965","authenticated-orcid":false,"given":"Valerio","family":"Nardone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca Maria","family":"Giugliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso","family":"Reginelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Sangiovanni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Mormile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciano","family":"Iadanza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Cappabianca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3687-2006","authenticated-orcid":false,"given":"Cesare","family":"Guida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.radonc.2020.06.048_b0005","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1080\/02841860310013490","article-title":"Extracranial stereotactic radioablation: physical principles","volume":"42","author":"Papiez","year":"2003","journal-title":"Acta Oncol"},{"issue":"11","key":"10.1016\/j.radonc.2020.06.048_b0010","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1001\/jama.2010.261","article-title":"Stereotactic body radiation therapy for inoperable early stage lung cancer","volume":"303","author":"Timmerman","year":"2010","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.radonc.2020.06.048_b0015","doi-asserted-by":"crossref","first-page":"e305","DOI":"10.1016\/j.ijrobp.2011.04.034","article-title":"Which is the optimal biologically effective dose of stereotactic body radiotherapy for Stage I non-small-cell lung cancer? A meta-analysis","volume":"81","author":"Zhang","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2020.06.048_b0020","doi-asserted-by":"crossref","unstructured":"Shioyama Y, Onishi H. Clinical outcomes of stereotactic body radiotherapy for patients with stage I small-cell lung cancer: analysis of a subset of the Japanese radiological society multi-institutional SBRT Study Group Database. 2018;17:1533033818783904.","DOI":"10.1177\/1533033818783904"},{"key":"10.1016\/j.radonc.2020.06.048_b0025","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1080\/14737140.2018.1458615","article-title":"The effects of radiotherapy on the survival of patients with unresectable non-small cell lung cancer","volume":"18","author":"Tini","year":"2018","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.radonc.2020.06.048_b0030","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s13246-012-0178-5","article-title":"Four dimensional radiotherapy: a review of current technologies and modalities","volume":"35","author":"Moorrees","year":"2012","journal-title":"Australas Phys Eng Sci Med"},{"key":"10.1016\/j.radonc.2020.06.048_b0035","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/j.semradonc.2003.10.006","article-title":"4-Dimensional computed tomography imaging and treatment planning","volume":"14","author":"Keall","year":"2004","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.radonc.2020.06.048_b0040","doi-asserted-by":"crossref","first-page":"4949","DOI":"10.1120\/jacmp.v16i2.4949","article-title":"Evaluation of 4D CT acquisition methods designed to reduce artifacts","volume":"16","author":"Castillo","year":"2015","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.radonc.2020.06.048_b0045","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13014-016-0699-2","article-title":"To gate or not to gate \u2013 dosimetric evaluation comparing Gated vs. ITV-based methodologies in stereotactic ablative body radiotherapy (SABR) treatment of lung cancer","volume":"11","author":"Kim","year":"2016","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2020.06.048_b0050","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ijrobp.2012.04.032","article-title":"Quantification and minimization of uncertainties of internal target volume for stereotactic body radiation therapy of lung cancer","volume":"85","author":"Ge","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2020.06.048_b0055","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/acm2.12431","article-title":"Evaluation of automatic contour propagation in T2-weighted 4DMRI for normal-tissue motion assessment using internal organ-at-risk volume (IRV)","volume":"19","author":"Zhang","year":"2018","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.radonc.2020.06.048_b0060","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0167-8140(02)00015-4","article-title":"Margins for geometric uncertainty around organs at risk in radiotherapy","volume":"62","author":"McKenzie","year":"2002","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.06.048_b0065","doi-asserted-by":"crossref","first-page":"e647","DOI":"10.1016\/j.ijrobp.2011.08.024","article-title":"Image-guided radiotherapy for left-sided breast cancer patients: geometrical uncertainty of the heart","volume":"82","author":"Topolnjak","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2020.06.048_b0070","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1097\/JTO.0b013e318074e4fa","article-title":"The North American experience with stereotactic body radiation therapy in non-small cell lung cancer","volume":"2","author":"Timmerman","year":"2007","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2020.06.048_b0075","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.radonc.2007.12.012","article-title":"Defining the margins in the radical radiotherapy of non-small cell lung cancer (NSCLC) with active breathing control (ABC) and the effect on physical lung parameters","volume":"87","author":"Panakis","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.06.048_b0080","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3109\/0284186X.2014.970666","article-title":"Impact of target volume segmentation accuracy and variability on treatment planning for 4D-CT-based non-small cell lung cancer radiotherapy","volume":"54","author":"Martin","year":"2015","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2020.06.048_b0085","doi-asserted-by":"crossref","first-page":"i53","DOI":"10.1093\/jrr\/rrw016","article-title":"Hypofractionated ablative radiotherapy for locally advanced pancreatic cancer","volume":"57","author":"Crane","year":"2016","journal-title":"J Radiat Res"},{"key":"10.1016\/j.radonc.2020.06.048_b0090","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejmp.2017.04.010","article-title":"Organs at risk in lung SBRT","volume":"44","author":"De Rose","year":"2017","journal-title":"Phys Med"},{"key":"10.1016\/j.radonc.2020.06.048_b0095","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ijrobp.2015.07.2260","article-title":"A Randomized phase 2 study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer: NRG Oncology RTOG 0915 (NCCTG N0927)","volume":"93","author":"Videtic","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2020.06.048_b0100","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1120\/jacmp.v13i6.4007","article-title":"Practical methods for improving dose distributions in Monte Carlo-based IMRT planning of lung wall-seated tumors treated with SBRT","volume":"13","author":"Altman","year":"2012","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.radonc.2020.06.048_b0105","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.clon.2017.09.007","article-title":"UK consensus on normal tissue dose constraints for stereotactic radiotherapy","volume":"30","author":"Hanna","year":"2018","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.radonc.2020.06.048_b0110","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13014-018-1001-6","article-title":"Stereotactic ablative radiotherapy for ultra-central lung tumors: prioritize target coverage or organs at risk?","volume":"13","author":"Murrell","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2020.06.048_b0115","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1748-717X-3-36","article-title":"Normal tissue toxicity after small field hypofractionated stereotactic body radiation","volume":"3","author":"Milano","year":"2008","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2020.06.048_b0120","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1016\/j.ejca.2009.08.011","article-title":"Stereotactic body radiation therapy for liver metastases","volume":"45","author":"Dawood","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2020.06.048_b0125","doi-asserted-by":"crossref","unstructured":"King CR, Brooks JD, Gill H, Presti JC, Jr. Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer. Int J Radiat Oncol Biol Phys 2012;82(2):877-82\/.","DOI":"10.1016\/j.ijrobp.2010.11.054"},{"key":"10.1016\/j.radonc.2020.06.048_b0130","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/1097-0142(197702)39:2+<729::AID-CNCR2820390707>3.0.CO;2-K","article-title":"Radiation toxicology: quantitative radiation pathology for predicting effects","volume":"39","author":"Rubin","year":"1977","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2020.06.048_b0135","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0360-3016(91)90171-Y","article-title":"Tolerance of normal tissue to therapeutic irradiation","volume":"21","author":"Emami","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2020.06.048_b0140","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.ijrobp.2009.07.1754","article-title":"Use of normal tissue complication probability models in the clinic","volume":"76","author":"Marks","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2020.06.048_b0145","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.ijrobp.2006.04.031","article-title":"Mid-ventilation CT scan construction from four-dimensional respiration-correlated CT scans for radiotherapy planning of lung cancer patients","volume":"65","author":"Wolthaus","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2020.06.048_b0150","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.radonc.2017.11.021","article-title":"Benefit of using motion compensated reconstructions for reducing inter-observer and intra-observer contouring variation for organs at risk in lung cancer patients","volume":"126","author":"McWilliam","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.06.048_b0155","doi-asserted-by":"crossref","DOI":"10.1002\/mp.14023","article-title":"Real-time 4D-MRI-based internal target volume definition for moving lung tumors","author":"Rabe","year":"2020","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2020.06.048_b0160","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/acm2.12699","article-title":"Clinical evaluation of 4D MRI in the delineation of gross and internal tumor volumes in comparison with 4DCT","volume":"20","author":"Zhang","year":"2019","journal-title":"J Appl Clin Med Phys"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814020303844?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814020303844?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:10:31Z","timestamp":1759122631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814020303844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":32,"alternative-id":["S0167814020303844"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2020.06.048","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"4D CT analysis of organs at risk (OARs) in stereotactic radiotherapy","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2020.06.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}